These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34961465)

  • 1. The Impact of Polyphenolics in the Management of Breast Cancer: Mechanistic Aspects and Recent Patents.
    El-Nashar HAS; Aly SH; Ahmadi A; El-Shazly M
    Recent Pat Anticancer Drug Discov; 2022; 17(4):358-379. PubMed ID: 34961465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Anticancer Potentials of Polyphenols: A Comprehensive Review of Patents in the Last Five Years.
    Gupta N; Singh S; Chauhan D; Srivastava R; Singh VK
    Recent Pat Anticancer Drug Discov; 2023; 18(1):3-10. PubMed ID: 35549878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Drugs for the Treatment of Breast Cancer Brain Metastasis: A Review of Patent Literature.
    Anaya-Ruiz M; Bandala C; Martinez-Morales P; Landeta G; Martinez-Contreras RD; Martinez-Montiel N; Perez-Santos M
    Recent Pat Anticancer Drug Discov; 2018; 13(3):348-359. PubMed ID: 29708077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant Polyphenolic Compounds Potentiates Therapeutic Efficiency of Anticancer Chemotherapeutic Drugs: A Review.
    Oruganti L; Meriga B
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):246-252. PubMed ID: 32767950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020).
    Fotopoulou E; Titilas I; Ronconi L
    Recent Pat Anticancer Drug Discov; 2022; 17(1):42-54. PubMed ID: 34493191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.
    Bonofiglio D; Giordano C; De Amicis F; Lanzino M; Andò S
    Mini Rev Med Chem; 2016; 16(8):596-604. PubMed ID: 26156544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations.
    Khan MI; Bouyahya A; Hachlafi NEL; Menyiy NE; Akram M; Sultana S; Zengin G; Ponomareva L; Shariati MA; Ojo OA; Dall'Acqua S; Elebiyo TC
    Environ Sci Pollut Res Int; 2022 Apr; 29(17):24411-24444. PubMed ID: 35064485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years.
    Zhu L; Li K; Liu M; Liu K; Ma S; Cai W
    Recent Pat Anticancer Drug Discov; 2022; 17(3):218-230. PubMed ID: 34886780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of quercetin on human breast cancer in different dimensions.
    Kasiri N; Rahmati M; Ahmadi L; Eskandari N; Motedayyen H
    Inflammopharmacology; 2020 Feb; 28(1):39-62. PubMed ID: 31754939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review.
    Ahmed ZSO; Golovoy M; Abdullah Y; Ahmed RSI; Dou QP
    Recent Pat Anticancer Drug Discov; 2021; 16(2):161-186. PubMed ID: 34132186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer.
    Sartaj A; Baboota S; Ali J
    Curr Cancer Drug Targets; 2020; 20(8):603-615. PubMed ID: 32228423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib - First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature.
    Vora PA; Patel R; Dharamsi A
    Recent Pat Anticancer Drug Discov; 2020; 15(2):113-131. PubMed ID: 32234004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020).
    Zheng YC; Liu YJ; Gao Y; Wang B; Liu HM
    Recent Pat Anticancer Drug Discov; 2022; 17(1):9-25. PubMed ID: 34323202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apigenin and Breast Cancers: From Chemistry to Medicine.
    Nabavi SM; Habtemariam S; Daglia M; Nabavi SF
    Anticancer Agents Med Chem; 2015; 15(6):728-35. PubMed ID: 25738871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New molecular targets of breast cancer therapy.
    Sauer G; Deissler H; Kurzeder C; Kreienberg R
    Strahlenther Onkol; 2002 Mar; 178(3):123-33. PubMed ID: 11962188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.
    Ganesan K; Du B; Chen J
    Pharmacol Res; 2022 Apr; 178():105974. PubMed ID: 34818569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Development of Selective Mcl-1 Inhibitors for the Treatment of Cancer (2017-Present).
    Fan Y; Hou X; Fang H
    Recent Pat Anticancer Drug Discov; 2020; 15(4):306-320. PubMed ID: 32938354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.